State Street’s Zymergen Inc. Common Stock ZY Stock Holding History

State Street’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-153,078	Closed	-$426K	–	4980
2022 Q3	$426K	Buy	153,078 +96,400	+170%	+$234K	﹤0.01%	3838
2022 Q2	$70K	Sell	56,678 -1,098,785	-95%	-$1.84M	﹤0.01%	4653
2022 Q1	$3.34M	Buy	1,155,463 +106,413	+10%	+$452K	﹤0.01%	3365
2021 Q4	$7.02M	Buy	1,049,050 +731,471	+230%	+$7.1M	﹤0.01%	3084
2021 Q3	$4.18M	Buy	317,579 +17,054	+6%	+$362K	﹤0.01%	3328
2021 Q2	$12M	Buy	+300,525	New	+$11.9M	﹤0.01%	2807

State Street's ZY Position: Q4 2022 in Review

State Street sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 153,078 shares — an estimated $426K sold.

State Street first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $12M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

State Street reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
State Street sold 153,078 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $426K.
State Street first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
State Street's Zymergen Inc. Common Stock position peaked at $12M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.